DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Uschner F, Nikolova I, Klein S. , et al.
The multikinase inhibitor regorafenib improves portal hypertension in presence and absence of cirrhosis in rats.
J Hepatol 2016;
64: S134-S135
We do not assume any responsibility for the contents of the web pages of other providers.